GGrantIndex
Sort

261,768 grants matching gene therapy

Epithelial Genes in Allergic Inflammation

$1,359,258
Gurjit K Khurana Hershey · Cincinnati Childrens Hosp Med Ctr · U19 · FY2021 · AI

Allogeneic Hematopoietic Transplantation for Primary Immunodeficiency Diseases

$1,359,238
Dennis Hickstein · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA

CANCER CENTER SUPPORT GRANT

$1,359,039
University Of Utah · P30 · FY2002 · CA

Uncovering cellular and molecular adaptations for whole-organism rejuvenation

$1,359,000
Blair Whitney Benham-Pyle · Baylor College Of Medicine · DP2 · FY2024 · AG

Tumor suppressor vulnerability conferred by aneuploid loss of haploinsufficient metallothionein genes

$1,359,000
Joe R Delaney · Medical University Of South Carolina · DP2 · FY2022 · CA

Molecular And Pharmacological Studies Of Dopamine Receptors

$1,358,962
David Sibley · National Institute Of Neurological Disorders And Stroke · ZIA · FY2009 · NS

Molecular and Clinical Studies of Primary Immunodeficiencies

$1,358,769
Fabio Candotti · National Human Genome Research Institute · ZIA · FY2014 · HG

DNA VIRUS AS VECTORS FOR CARDIOVASCULAR DISEASES

$1,358,676
University Of Pennsylvania · P01 · FY2002 · HL

Investigation of viral and host determinants of gammaherpesvirus pathogenesis

$1,358,576
Laurie T Krug · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA

Engineered HSV For Treatment of Malignant Glioma

$1,358,565
Richard J. Whitley · University Of Alabama At Birmingham · P01 · FY2009 · CA

Center for Molecular Imaging Research at MGH/HMS

$1,358,452
Ralph Weissleder · Massachusetts General Hospital · P50 · FY2012 · CA

HIV-1 Integrase

$1,358,421
Stephen H Hughes · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA

Developmental Mechanisms of Human Idiopathic Scoliosis

$1,358,310
Carol A Wise · Ut Southwestern Medical Center · P01 · FY2023 · HD

IND-enabling safety and toxicity testing of a subcutaneous formulation of the PTP1B inhibitor MSI-1436, a novel strategy for treating fatal cardiomyopathy in Duchenne muscular dystrophy patients

$1,358,179
Kevin Strange · Revidia Therapeutics, Inc · R44 · FY2024 · HL

Acute Hepatitis C Infection in Young Injectors

$1,358,160
Kimberly Page · University Of New Mexico Health Scis Ctr · R01 · FY2017 · DA

Necrotic survivors and plasma membrane integrity signaling

$1,358,083
Yi-Nan Gong · University Of Pittsburgh At Pittsburgh · DP2 · FY2021 · GM

Disseminating Curative Biological Therapies for Rare Pediatric Diseases

$1,357,953
David A Williams · Boston Children'S Hospital · U01 · FY2019 · TR

Gene Therapy for Brain Tumors

$1,357,853
Fred H Hochberg · Massachusetts General Hospital · P01 · FY2007 · CA

Novel diagnostics and therapeutics for caliciviruses

$1,357,751
Mary Kolb Estes · Baylor College Of Medicine · P01 · FY2006 · AI

Characterization of the Osteosarcoma Genome

$1,357,574
Paul S. Meltzer · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA

Developmental Core

$1,357,555
Karen Hubbard · City College Of New York · U54 · FY2009 · CA

Retinal Ganglion Cell Replacement in Optic Neuropathies

$1,357,464
Jeffrey L Goldberg · Stanford University · U24 · FY2021 · EY

UCSF Stanford Endometriosis Center for Discovery, Innovation, Training and Community Engagement

$1,357,391
Linda C Giudice · University Of California, San Francisco · P01 · FY2025 · HD

Porphyrias Consortium

$1,357,363
Robert J Desnick · Icahn School Of Medicine At Mount Sinai · U54 · FY2020 · DK

A comprehensive research resource to define mechanisms underlying microbial regulation of host metabolism in pediatric obesity and obesity-targeted therapeutics

$1,357,294
John F Rawls · Duke University · R24 · FY2019 · DK